Cargando…
A single-cell map of antisense oligonucleotide activity in the brain
Antisense oligonucleotides (ASOs) dosed into cerebrospinal fluid (CSF) distribute broadly throughout the brain and hold the promise of treating myriad brain diseases by modulating RNA. CNS tissue is not routinely biopsied in living individuals, leading to reliance on CSF biomarkers to inform on drug...
Autores principales: | Mortberg, Meredith A, Gentile, Juliana E, Nadaf, Naeem, Vanderburg, Charles, Simmons, Sean, Dubinsky, Dan, Slamin, Adam, Maldonado, Salome, Petersen, Caroline L, Jones, Nichole, Kordasiewicz, Holly B, Zhao, Hien T, Vallabh, Sonia M, Minikel, Eric Vallabh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948956/ https://www.ncbi.nlm.nih.gov/pubmed/36824749 http://dx.doi.org/10.1101/2023.02.14.528473 |
Ejemplares similares
-
A single-cell map of antisense oligonucleotide activity in the brain
por: Mortberg, Meredith A, et al.
Publicado: (2023) -
Characterization of the Prion Protein Binding Properties of Antisense Oligonucleotides
por: Reidenbach, Andrew G., et al.
Publicado: (2019) -
Analysis of non-human primate models for evaluating prion disease therapeutic efficacy
por: Mortberg, Meredith A., et al.
Publicado: (2022) -
Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trials
por: Mortberg, Meredith A., et al.
Publicado: (2022) -
Antisense oligonucleotides extend survival of prion-infected mice
por: Raymond, Gregory J., et al.
Publicado: (2019)